News Radio KOTA
    • Sample Page
Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas

Author: Balt Group

Posted Date:

February 4, 2026
  • Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas

    Balt Group
    February 4, 2026